|
|
Volumn 36, Issue 2, 2009, Pages 437-439
|
|
Marked regression of pulmonary rheumatoid nodules under etanercept therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETANERCEPT;
METHOTREXATE;
ANTIRHEUMATIC AGENT;
IMMUNOGLOBULIN G;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
ARTHRALGIA;
ARTICLE;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE ACTIVITY;
FEMALE;
HUMAN;
LUNG NODULE;
LUNG RHEUMATOID NODULE;
PRIORITY JOURNAL;
REMISSION;
RHEUMATOID ARTHRITIS;
RHEUMATOID NODULE;
SCORING SYSTEM;
SYNOVIUM;
TREATMENT DURATION;
DISEASE COURSE;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG EFFECT;
IMMUNOLOGY;
LUNG;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
RADIOGRAPHY;
TREATMENT OUTCOME;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DISEASE PROGRESSION;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
LUNG;
METHOTREXATE;
MIDDLE AGED;
MULTIPLE PULMONARY NODULES;
RECEPTORS, TUMOR NECROSIS FACTOR;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 64849115299
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: 10.3899/jrheum.080557 Document Type: Article |
|
Times cited : (8)
|
|
References (3)
|
